METHOD AND COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASE

METHOD AND COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASE

The neuropsychiatric symptom of bradyphrenia in a Parkinson's Disease patient may be ameliorated by treating the patient with a histamine H2-antagonist that passes the blood brain barrier. Suitable H2-antagonists include famotidine and ranitidine. The H2-antagonists may be co-administered with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: KAMINSKI, RAM
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The neuropsychiatric symptom of bradyphrenia in a Parkinson's Disease patient may be ameliorated by treating the patient with a histamine H2-antagonist that passes the blood brain barrier. Suitable H2-antagonists include famotidine and ranitidine. The H2-antagonists may be co-administered with other compounds such as histamine H1-antagonists which are known to be useful in the treatment of Parkinson's Disease, and can be formulated with such other compounds into a therapeutic composition.